Skip to main content

Table 1 The baseline characteristics of SCCC patients

From: Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets

Case

Age

HPV

Stage

Tumor size(cm)

Invasion depth

LVSI

LNM

DFS

OS

Prognosis

Ca001

51

18

IB3

4.5 × 3

 > 4/5

Negative

Negative

13

23

DOD

Ca002

38

16

IIIC1p

6 × 5

 > 4/5

Positive

Positive

31

41

DOD

Ca003

26

18

IIA2

5 × 3.5

2/3

Positive

Negative

8

13

DOD

Ca004

37

18/58

IIIC1p

4 × 2.5

2/3

Positive

Positive

8

17

DOD

Ca006

58

18/51

IB2

3.5 × 3.3

1/2

Negative

Negative

66

66

Alive

Ca007

60

Negative

IIIC1p

3.4 × 4.9

 > 4/5

Negative

Positive

11

16

DOD

Ca009

64

ND

IIA1

1 × 1

 < 1/3

Negative

Negative

19

31

DOD

Ca054

44

16/18

IIIC1p

3 × 3.5

3/4

Positive

Positive

22

27

DOD

Ca055

50

18/39

IB1

1.3 × 1

 < 1/3

Negative

Negative

10

15

DOD

Ca056

49

18

IIA1

3.5 × 2.4

 > 4/5

Negative

Negative

45

57

AWD

Ca057

29

18/45

IIIC1p

4.5 × 3.5

 > 4/5

Positive

Positive

22

39

DOD

Ca058

47

Negative

IB2

1.9 × 2.5

 < 1/3

Negative

Negative

62

62

Alive

Ca059

52

16

IB1

1.5 × 1

 > 4/5

Positive

Negative

13

16

DOD

Ca060

40

18

IB3

5.5 × 4

1/2

Negative

Negative

8

26

DOD

Ca061

44

Negative

IIIC1p

2.2 × 2

 > 4/5

Positive

Positive

29

48

DOD

Ca252

38

ND

IIB

2.8 × 2.0

 > 4/5

Positive

Negative

6

30

DOD

Ca253

30

18/52/66

IIIC1p

1.2 × 1.6

 > 1/2

Positive

Positive

7

15

DOD

Ca254

48

33/51

IB2

2.3 × 1.7

 > 4/5

Positive

Negative

18

27

DOD

  1. ND: not detected; LVSI: lymphovascular invasion; LNM: lympho node metastasis; DFS: disease-free survival; OS: overall survival; DOD: dead of disease; AWD: alive with recurrent disease